The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...

Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra, the second brand of Wegovy.

Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...

US-based pharma giant Eli Lilly’s blockbuster weight-loss drug, Mounjaro, is set to expand its reach across India through a ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

People taking popular new weight-loss drugs such as Wegovy and Zepbound often celebrate the number of pounds they shed and the related health benefits, but many doctors at weight-loss clinics are ...

PLAINSBORO, N.J., and BAGSVÆRD, Denmark, Oct. 20, 2025 /PRNewswire/ -- Novo Nordisk today announced new data on the investigational oral semaglutide 25 mg will be among 23 abstracts to be presented at ...

The weight-loss drug Wegovy curbs the risk of heart attacks and other cardiovascular problems, even among people who don’t lose much weight on the drug or don't have severe obesity to start with, a ...

GLP-1 drugs for weight loss and diabetes may slow the rate at which alcohol enters the bloodstream, a small new study finds. A small study found that people taking GLP-1s experienced slower increases ...

The outgoing Biden administration in its waning days sought to extend Medicare and Medicaid coverage to Wegovy and Zepbound, but the Trump administration shelved that effort. The deal announced ...